ProMIS Neurosciences Inc. (PMN)
ProMIS Neurosciences Statistics
Share Statistics
ProMIS Neurosciences has 32.69M shares outstanding. The number of shares has increased by 72.4% in one year.
| Shares Outstanding | 32.69M |
| Shares Change (YoY) | 72.4% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 22.91M |
| Failed to Deliver (FTD) Shares | 186 |
| FTD / Avg. Volume | 0.45% |
Short Selling Information
The latest short interest is 239.78K, so 0.73% of the outstanding shares have been sold short.
| Short Interest | 239.78K |
| Short % of Shares Out | 0.73% |
| Short % of Float | 1.05% |
| Short Ratio (days to cover) | 2.64 |
Valuation Ratios
The PE ratio is 0.09 and the forward PE ratio is -1.49. ProMIS Neurosciences's PEG ratio is 0.
| PE Ratio | 0.09 |
| Forward PE | -1.49 |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 0.01 |
| P/FCF Ratio | -9.04 |
| PEG Ratio | 0 |
Enterprise Valuation
ProMIS Neurosciences has an Enterprise Value (EV) of -13.05B.
| EV / Sales | 0 |
| EV / EBITDA | 0.78 |
| EV / EBIT | 479.93 |
| EV / FCF | 479.93 |
Financial Position
The company has a current ratio of 8.52, with a Debt / Equity ratio of 0.
| Current Ratio | 8.52 |
| Quick Ratio | 8.52 |
| Debt / Equity | 0 |
| Debt / EBITDA | 0 |
| Debt / FCF | 0 |
| Interest Coverage | 219.18 |
Financial Efficiency
Return on Equity is 16.85% and Return on Invested Capital is -100.81%.
| Return on Equity | 16.85% |
| Return on Assets | 14.69% |
| Return on Invested Capital | -100.81% |
| Revenue Per Employee | $0 |
| Profits Per Employee | $463.15M |
| Employee Count | 6 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -76.25% in the last 52 weeks. The beta is 0.58, so ProMIS Neurosciences's price volatility has been higher than the market average.
| Beta | 0.58 |
| 52-Week Price Change | -76.25% |
| 50-Day Moving Average | 0.78 |
| 200-Day Moving Average | 1.11 |
| Relative Strength Index (RSI) | 33.74 |
| Average Volume (20 Days) | 41.46K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -16.83B |
| Net Income | 2.78B |
| EBITDA | -16.83B |
| EBIT | 2.7B |
| Earnings Per Share (EPS) | 10.72 |
Balance Sheet
The company has 13.29B in cash and 0 in debt, giving a net cash position of 13.29B.
| Cash & Cash Equivalents | 13.29B |
| Total Debt | 0 |
| Net Cash | 13.29B |
| Retained Earnings | -90.69B |
| Total Assets | 18.91M |
| Working Capital | 16.69M |
Cash Flow
In the last 12 months, operating cash flow was -27.18M and capital expenditures 0, giving a free cash flow of -27.18M.
| Operating Cash Flow | -27.18M |
| Capital Expenditures | 0 |
| Free Cash Flow | -27.18M |
| FCF Per Share | -0.1 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PMN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 1131.14% |
| FCF Yield | -11.06% |
Analyst Forecast
The average price target for PMN is $6, which is 952.6% higher than the current price. The consensus rating is "Buy".
| Price Target | $6 |
| Price Target Difference | 952.6% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Jun 28, 2022. It was a backward split with a ratio of 1:60.
| Last Split Date | Jun 28, 2022 |
| Split Type | backward |
| Split Ratio | 1:60 |
Scores
| Altman Z-Score | -2.65 |
| Piotroski F-Score | 4 |